Comprehensive longitudinal analysis of cellular immune responses and viral evolution in a person with acute HCV infection requiring antiviral treatment.

Comprehensive longitudinal analysis of cellular immune responses and viral evolution in a person with acute HCV infection requiring antiviral treatment.

Dades bibliogràfiques
Autors principals:	Lauer, G, Lucas, M, Chung, RT, Ouchi, K, Day, C, Kim, A, Klenerman, P, Walker, B
Format:	Conference item
Publicat:	2002

Ítems similars

Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
per: Lauer, G, et al.
Publicat: (2001)

T-cell responses during early therapy for HCV infection.
per: Lauer, G, et al.
Publicat: (2003)

CD8 epitope escape and reversion in acute HCV infection.
per: Timm, J, et al.
Publicat: (2004)

Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
per: Lauer, G, et al.
Publicat: (2002)

CTL epitope escape and reversion in acute HCV infection.
per: Timm, J, et al.
Publicat: (2004)

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.
per: Lauer, G, et al.
Publicat: (2004)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
per: Pfafferott, K, et al.
Publicat: (2011)

Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
per: Lauer, G, et al.
Publicat: (2002)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
per: Katja Pfafferott, et al.
Publicat: (2011-02-01)

Cellular immune responses against HCV: T cells take a diversion in the liver
per: Klenerman, P, et al.
Publicat: (2004)

Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.
per: Komatsu, H, et al.
Publicat: (2006)

Sarcoidosis during HCV antiviral therapy
per: Emanuela De Santis, et al.
Publicat: (2014-08-01)

Antiviral therapy in patients with HCV-cirrhosis
per: Josep Melero, et al.
Publicat: (2009-10-01)

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.
per: Marcus M Mücke, et al.
Publicat: (2019-01-01)

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.
per: Semmo, N, et al.
Publicat: (2006)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
Publicat: (2006-04-01)

Antiviral therapy in HCV-infected decompensated cirrhotics
per: Danish Fazal, et al.
Publicat: (2010-01-01)

Discovery of cellular proteins required for the early steps of HCV infection using integrative genomics.
per: Ji Hoon Park, et al.
Publicat: (2013-01-01)

CD8AA T CELLS: A NOVEL LINEAGE ENRICHED IN THE LIVER IN CHRONIC HCV
per: Walker, L, et al.
Publicat: (2010)

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
per: Ahmed El Ray, et al.
Publicat: (2023-02-01)

HIV has a significant impact on the early HCV host-viral responses
per: Danta, M, et al.
Publicat: (2006)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
per: Rohrbach, J, et al.
Publicat: (2010)

Cellular immune responses against hepatitis C virus: the evidence base 2002.
per: Ward, S, et al.
Publicat: (2002)

Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.
per: Anna Rosa Garbuglia, et al.
Publicat: (2016-01-01)

Cardiac toxicity associated with HCV direct antiviral agents
per: Claudio Ucciferri, et al.
Publicat: (2018-10-01)

Treatment of Chronic HCV Infection with Direct Acting Antivirals
per: Bekhbold Dashtseren, et al.
Publicat: (2021-09-01)

Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent.
per: Hyock Joo Kwon, et al.
Publicat: (2015-01-01)

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters
per: Joana Ferreira, et al.
Publicat: (2024-02-01)

Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.
per: Lucas, M, et al.
Publicat: (2004)

Hepatitis C virus (HCV) cellular immune responses are induced during combination therapy but are not sustained.
per: Barnes, E, et al.
Publicat: (2000)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
per: Óscar Brochado-Kith, et al.
Publicat: (2021-08-01)

Death or glory for antiviral T cells
per: Klenerman, P, et al.
Publicat: (2007)

Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico
per: Ricardo Jimenez-Mendez, et al.
Publicat: (2010-01-01)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
per: Kasprowicz, V, et al.
Publicat: (2011)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
per: Kasprowicz, V, et al.
Publicat: (2008)

Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.
per: Day, C, et al.
Publicat: (2008)

HCV-indeterminate blood donors or occult HCV infection? Reply
per: Semmo, N, et al.
Publicat: (2005)

The Future of HCV Therapy: NS4B as an Antiviral Target
per: Hadas Dvory-Sobol, et al.
Publicat: (2010-11-01)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
per: Vicente Soriano, et al.
Publicat: (2017-10-01)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
per: Andrea Angeletti, et al.
Publicat: (2019-02-01)